Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAnbio Biotechnology Class A Ordinary Shares Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 06/29/2025 | Q2 2025 | N/A | $0.09 | N/A | N/A | $5.01 M |
| 12/31/2024 | Q4 2024 | N/A | -$0.03 | N/A | N/A | $2.53 M |
| 06/30/2024 | Q2 2024 | N/A | $0.09 | N/A | N/A | $6.32 M |
| 12/31/2023 | Q4 2023 | N/A | $0.02 | N/A | N/A | $3.95 M |
| 06/30/2023 | Q2 2023 | N/A | $0.04 | N/A | N/A | $3.31 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Anbio Biotechnology Class A Ordinary Shares Earnings: FAQ's
Anbio Biotechnology Class A Ordinary Shares has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, April 28th, 2025 based offlast year's report dates.
The conference call for Anbio Biotechnology Class A Ordinary Shares's latest earnings report can be listened to online.
The conference call transcript for Anbio Biotechnology Class A Ordinary Shares's latest earnings report can be read online.
Anbio Biotechnology Class A Ordinary Shares (:NNNN) has a recorded annual revenue of $8.19 M.
Anbio Biotechnology Class A Ordinary Shares (:NNNN) has a recorded net income of $2.37 M.Anbio Biotechnology Class A Ordinary Shares has generated $0.056 earnings per share over the last four quarters.
Anbio Biotechnology Class A Ordinary Shares (:NNNN) has a price-to-earnings ratio of 299.89 and price/earnings-to-growth ratio is 69.9.